AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next
Nasdaq said Friday that Walmart will replace AstraZeneca in the Nasdaq-100 before trading opens Jan. 20. AstraZeneca’s U.S. shares closed at $94.65, up 0.68%, with volume near 6.1 million. Investors are watching AstraZeneca’s management talks at the J.P. Morgan Healthcare Conference Jan. 12–14 and its full-year results on Feb. 10.